XNCR
XencorDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
XNCR vs peer average
31/100
XNCR vs. peer average (D vs. C)
Grade spread
A 2 · B 2 · C 3 · D 2 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ABUS is the first available peer comparator.
Small-cap clinical biotech comp by size, but not a close operating peer; useful mainly as a sentiment/risk benchmark for binary development-stage names.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
XNCR
Xencor
ABUS
Arbutus Biopharma
Grade
D
C
Momentum
92
40
Value
41
41
Sentiment
7
72
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs ABUS
XNCR / ABUS
Grade Position
Below peers
XNCR vs. peer average (D vs. C)
31/100
Momentum
92
XNCRValue
41
XNCRSentiment
7
ABUSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs XNCR
ABUS is the first peer returned for this comparison set.